Clinical evaluation of cetylpyridinium chloride-containing mouthwash in halitosis |
Kang, Minkyung
(Dong-A Pharmaceutical Research Laboratories)
Kim, Boyeon (Dong-A Pharmaceutical Research Laboratories) Park, Hyounggeun (Dong-A Pharmaceutical Research Laboratories) Lee, Eunseok (Dong-A Pharmaceutical Research Laboratories) |
1 | Tangerman A. Halitosis in medicine: a review. Int Dent J 2002;52 Suppl 3:201-6. doi: 10.1002/j.1875-595X.2002.tb00925.x. DOI |
2 | Seerangaiyan K, van Winkelhoff AJ, Harmsen HJM, Rossen JWA, Winkel EG. The tongue microbiome in healthy subjects and patients with intra-oral halitosis. J Breath Res 2017;11:036010. doi: 10.1088/1752-7163/aa7c24. DOI |
3 | Tangerman A, Winkel EG. Extra-oral halitosis: an overview. J Breath Res 2010;4:017003. doi: 10.1088/1752-7155/4/1/017003. DOI |
4 | Quirynen M, Dadamio J, Van den Velde S, De Smit M, Dekeyser C, Van Tornout M, Vandekerckhove B. Characteristics of 2000 patients who visited a halitosis clinic. J Clin Periodontol 2009;36:970-5. doi: 10.1111/j.1600-051X.2009.01478.x. DOI |
5 | Seemann R, Duarte da Conceicao M, Filippi A, Greenman J, Lenton P, Nachnani S, Quirynen M, Roldan S, Schulze H, Sterer N, Tangerman A, Winkel EG, Yaegaki K, Rosenberg M. [Halitosis management by the general dental practitioner-results of an International Consensus Workshop]. Swiss Dent J 2014;124:1205-11. German. doi: 10.1088/1752-7155/8/1/017101. |
6 | Kazor CE, Mitchell PM, Lee AM, Stokes LN, Loesche WJ, Dewhirst FE, Paster BJ. Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patients. J Clin Microbiol 2003;41:558-63. doi: 10.1128/JCM.41.2.558-563.2003. DOI |
7 | Kang JH, Kim DJ, Choi BK, Park JW. Inhibition of malodorous gas formation by oral bacteria with cetylpyridinium and zinc chloride. Arch Oral Biol 2017;84:133-8. doi: 10.1016/j.archoralbio.2017.09.023. DOI |
8 | Hughes FJ, McNab R. Oral malodour--a review. Arch Oral Biol 2008;53 Suppl 1:S1-7. doi: 10.1016/S0003-9969(08)70002-5. DOI |
9 | Pitts G, Pianotti R, Feary TW, McGuiness J, Masurat T. The in vivo effects of an antiseptic mouthwash on odor-producing microorganisms. J Dent Res 1981;60:1891-6. doi: 10.1177/00220345810600111101. DOI |
10 | Liu J, Ling JQ, Wu CD. Cetylpyridinium chloride suppresses gene expression associated with halitosis. Arch Oral Biol 2013;58:1686-91. doi: 10.1016/j.archoralbio.2013.08.014. DOI |
11 | Renton-Harper P, Addy M, Moran J, Doherty FM, Newcombe RG. A comparison of chlorhexidine, cetylpyridinium chloride, triclosan, and C31G mouthrinse products for plaque inhibition. J Periodontol 1996;67:486-9. doi: 10.1902/jop.1996.67.5.486. DOI |
12 | Feres M, Figueiredo LC, Faveri M, Guerra MC, Mateo LR, Stewart B, Williams M, Panagakos F. The efficacy of two oral hygiene regimens in reducing oral malodour: a randomised clinical trial. Int Dent J 2015;65:292-302. doi: 10.1111/idj.12183. DOI |
13 | Mandel ID. Chemotherapeutic agents for controlling plaque and gingivitis. J Clin Periodontol 1988;15:488-94. doi: 10.1111/j.1600-051X.1988.tb01020.x. DOI |
14 | European Commission. Scientific Committee on Consumer Products: opinion on cetylpyridinium chloride. Brussels: European Commission; 2006 Mar. SCCP/0985/06. 5 p. |
15 | Sreenivasan PK, Haraszthy VI, Zambon JJ. Antimicrobial efficacy of cetylpyridinium chloride mouthrinses. Lett Appl Microbiol 2013;56:14-20. doi: 10.1111/lam.12008. DOI |